News Breaks |
|
|
| January 9, 2013 |
| 19:31 EDT |  | GSK, PFE | GlaxoSmithKline says no plans for ViiV spinoff, Bloomberg reports GlaxoSmithKline (GSK) says that it currently does not have plans to spinoff its ViiV Healthcare unit, which is developing HIV treatments, according to a Bloomberg report. GSK holds a 76.5% stake in ViiV, while Pfizer (PFE) holds a 13.5% stake, and Japanese drugmaker Shionogi holds the other 10% stake, the report says. Reference Link |
|
|
News For GSK;PFE From The Last 14 Days Check below for free stories on GSK;PFE the last two weeks. |
|
|
| May 6, 2013 |
| 08:02 EDT |  | PFE | Pfizer launches Viagra home delivery, powered by CVS/pharmacy To meet the needs of consumers who are increasingly going online to purchase prescription medications, Pfizer (PFE) launched Viagra home delivery, a new prescription-fulfillment website for Viagra tablets, Pfizer’s most counterfeited medicine. The site, which is powered by CVS/pharmacy (CVS) and accessible through Viagra.com, offers men with erectile dysfunction an opportunity to purchase Viagra online with a valid prescription from a trusted source. |
|
| 07:51 EDT |  | PFE | Pfizer to sell Viagra directly to patients on its website, Fox News reports In a move that changes the drug industry's distribution model, Pfizer told The Associated Press that it will begin selling Viagra directly to patients on its website, reports Fox News. Men still will need a prescription to buy it, and Pfizer is offering three free pills with the first order and 30% off the second one. Reference Link |
|
| 07:49 EDT |  | GSK | Bernstein's global pharmaceuticals analyst has analyst/industry conference call
Subscribe for More Information |
|
| 07:34 EDT |  | PFE | Conference Forum to host a summit
Subscribe for More Information |
|
| 07:24 EDT |  | PFE | Drug companies attempt to make painkillers that can't be abused, WSJ reports
Subscribe for More Information |
|
| 07:18 EDT |  | PFE | American Congress of Obstetrics and Gynecology to hold annual meeting
Subscribe for More Information |
|
|
|
|
|